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Summary 
The current view of lymphocyte migration states that naïve lymphocytes re-circulate between the 
blood and the lymph via the lymph nodes but are not able to access non-lymphoid tissues. We 
examined B lymphocytes in peripheral tissues and found that the majority were phenotypically 
similar to naïve B cells in lymphoid tissue and were located within the parenchyma, not 
associated with blood vessels. The mutation rate within the Vh region of these cells was 
substantially less than the rate attributed to somatic hypermutation and was identical to that 
observed in naïve B cells isolated from the lymph nodes, demonstrating the presence of naïve B 
cells in the non-lymphoid organs. Further, using FTY720 treated mice, we showed that naïve B 
cells migrate through the peripheral tissues and, using pertussis toxin, that the entry of B cells 
was not controlled by chemokine-mediated signalling events. Overall, these results demonstrate 
that naïve B lymphocytes constitute the majority of the total B cell population in non-lymphoid 
tissues and suggest that these cells may re-circulate through the periphery as part of their normal 
migration pathway. This has implications for the current view of the role of naïve B cells in 
priming and tolerance.   
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Introduction 
In order to function effectively, the immune system must integrate complex signals from 
specialised immune microenvironments (such as the lymph nodes) and immune effector sites 
throughout the body. This allows the maintenance of a balance between priming and tolerance 
and ensures that disease states, such as autoimmunity, do not develop. It is now well established 
that the initial induction of priming or tolerance in naïve lymphocytes occurs in the organised 
lymphoid tissues and requires rapid migration of cells to these sites after antigen challenge. 
Therefore, an understanding of the migration patterns of naïve T and B lymphocytes is central in 
dissecting the complex mechanisms by which different types of immune response occur. 
Early studies by Gowans and colleagues [1-2] provided the foundations for our current 
understanding of naïve lymphocyte migration, indicating that these cells undergo continuous 
recirculation between the blood and the lymph via the lymph nodes. Further studies have 
reinforced these findings, demonstrating that naïve lymphocytes are able to enter the organised 
lymphoid tissue by binding to high endothelial venules (HEVs) [3-6]. Until recently, the 
discovery of these mechanisms and the absence of HEVs in peripheral tissues have resulted in 
the commonly held belief that naïve lymphocytes are not able to access non-lymphoid tissues 
easily or in any substantial numbers [7-8]. Studies demonstrating heterogeneity in the expression 
of tissue-specific homing molecules on memory and effector (but not naïve) lymphocytes have 
also added weight to this argument. 
In contrast to this view, a recent study in normal adult mice has suggested that a significant 
number of CD4+ and CD8+ T lymphocytes in non-lymphoid tissues have a naïve phenotype [9]. 
In addition, earlier studies have suggested that naïve T lymphocytes may be found in the 
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peripheral tissues in the neonate [10] and under inflammatory conditions [8, 11]. However, these 
and other studies demonstrating entry of phenotypically naïve T cells to non-lymphoid tissues 
after adoptive transfer [12-14] have been hampered by either the absence of data indicating 
functional naivety or the difficulties associated with presenting conclusive phenotypic data in T 
lymphocytes. 
The literature examining naïve B cell recirculation is less comprehensive, with the more recent 
migration studies focusing on T lymphocytes. However, given the importance of the role that B 
cells play in the generation of tolerance and effector responses, patterns of naïve B cell migration 
clearly warrant further investigation. In addition, the phenomenon of somatic hypermutation 
allows the definitive separation of B cells that have (memory or effector cells) or have not (naïve 
cells) been exposed to antigen. The mutation rate attributable to somatic hypermutation has been 
estimated at approximately 1-4x10-3 per base pair (bp) per cell generation [15-16], significantly 
higher than the spontaneous mutation rate [17]. Therefore, sequencing experiments allow the 
identification of naïve and effector/memory B cells. 
In this study, by phenotypic and sequence analysis of immunoglobulin hypermutation, we 
demonstrate that the majority of the total B lymphocytes in non-lymphoid tissues are 
indistinguishable from their naïve lymph node counterparts. We go on to show, with the use of 
FTY720, that these cells actively migrate into peripheral tissues and that chemokine-mediated 
signalling is not necessary for their entry. These findings challenge the established belief that 
naïve B lymphocytes are unable to enter non-lymphoid tissue and indicate that a review of the 
involvement of naïve B cells in priming and tolerance induction would be timely.    
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Results 
B cells in peripheral tissues have a naïve phenotype 
Initial studies focused on examining the phenotype of B cells in lymphoid (peripheral lymph 
nodes (PLN), mesenteric lymph nodes (MLN) and spleen (SPL)) and non-lymphoid (liver (LIV), 
lung and intestinal lamina propria (LP)) tissues. Lymphocytes were isolated from these tissues 
and B cells were identified by the expression of CD19 by flow cytometry. Naïve B lymphocytes 
were then identified by co-expression of IgM and IgD. As expected, a high proportion (74-91%) 
of B lymphocytes in the lymphoid tissues had a naïve phenotype (Fig. 1A). Surprisingly, when 
the analysis was repeated in non-lymphoid tissues, over 50% of the total B cell population in the 
LP and over 60% in the liver and lung co-expressed IgM and IgD (Fig. 1A and B), suggesting 
that the majority of B cells in peripheral tissues are, in fact, naïve. In addition, similar results 
were obtained using B220 rather than CD19 to identify B cells (Fig. S1). In order to further 
characterise the phenotype of these cells, they were isolated from the same tissues, stained with 
antibodies against B220 or CD19 and IgD and then with antibodies against molecules shown to 
differentiate naive and memory B cells [18] or molecules associated with activation (Table S1 
and Fig. S2; Table S2, Fig. S3 and Fig. S4). With the exception of CD73 in the LP, the mean 
fluorescent intensity (MFI) for each marker was comparable or significantly less on IgD+ B cells 
from  the non-lymphoid tissues when compared to IgD+ B cells from PLN (Table S1), indicating 
that they were phenotypically similar to the naïve B cells present in lymphoid tissue. In order to 
further characterise this unique B cell population in the peripheral tissues, we stained with 
antibodies against other molecules commonly associated with activation (Table S2). In the liver 
and lung, the expression of these molecules on IgD+ B cells was not significantly different to that 
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observed in the organised lymphoid tissue, again indicating that this B cell population in the 
peripheral tissues was phenotypically similar to the naïve B cell population in the lymph nodes 
and spleen. A similar pattern could be observed in the LP, although the MFI for CD11a and 
CD86 was significantly less and significantly greater, respectively, when compared to the 
organised lymphoid tissues although neither have been shown to be significantly different 
between naïve and memory B cell populations [18]. Overall these results indicate that a large 
proportion of the B cells present in non-lymphoid tissue are phenotypically identical to the naïve 
B cell population in organised lymphoid tissue.  
Naïve B cells in non-lymphoid tissues are not associated with blood vessels 
Despite perfusing the mice before harvesting the tissues, there was still a possibility that the IgD+ 
B cell population isolated from the peripheral tissues was present due to blood contamination: it 
was important to quantify the numbers of these cells in the parenchyma of the non-lymphoid 
tissues. Sections of lung, intestine, liver and spleen were stained to identify B220+/IgD+ B cells 
and CD31+ blood vessels. B220+/IgD+ B cells that were not associated with blood vessels (Fig. 
2A, Fig. S5A, Fig. S6) could be identified in all tissues. An analysis of the total area of 
B220+/IgD+ B cell staining showed that, with the exception of the lung, in all tissues the area of 
B220+/IgD+/CD31- staining was significantly greater than the area of B220+/IgD+/CD31+ staining 
(Fig. 2B), indicating that there were more B220+/IgD+ B cells present in the parenchyma of the 
tissues than in or associated with the blood vessels. Manual cell counting using the same images 
gave similar results (Fig. S7). In addition, the observed proportion of area which was positive 
both for B220 and IgD but not associated with CD31 was significantly greater than the area 
expected if the three target molecules were independently distributed in all tissues (Fig. S5B), 
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indicating that co-localization of B220+ and IgD+ area in the tissue parenchyma was due to 
genuine co-expression of these molecules by individual B cells and not due to overlap of these 
stains by random chance.  
Sequence analysis reveals no difference between tissue resident IgM+/IgD+ B cells and their 
naïve lymph node counterparts 
Despite the extensive flow-cytometric analysis indicating the presence of B cells with a naive 
phenotype in non-lymphoid tissues, there was still the possibility that the cells we had identified 
represented a memory/effector B lymphocyte population with a novel phenotype. It is well 
established that maturation of affinity of B cell responses is achieved by somatic hypermutation 
of immunoglobulin heavy and light chain genes and the selection of high affinity cells. This 
phenomenon allows the differentiation, by sequence analysis and enumeration of point 
mutations, of B cells that have (effector/memory) or have not (naïve) met antigen. If the B cells 
that we had so far identified in our studies were truly naïve, we would expect them to have a 
mutation rate similar to naïve B cells in secondary lymphoid organs and in any case far less than 
that expected from hypermutated immunoglobulin genes. Therefore, in order to ensure that these 
cells had not undergone somatic hypermutation, we extracted genomic DNA from flow-sorted 
B220+/IgM+/IgD+ cells and sequenced a 1.2Kb fragment spanning the 3’-flank of rearranged 
VHJ558 genes to the 3’-end of the IgH intronic enhancer [19]. We found that the mutation 
frequency in non-lymphoid tissues was not different from the mutation frequency of cells with 
the same surface phenotype from PLN (Table 1). In addition, in all non-lymphoid tissues the 
number of mutations per bp was 0.02-0.04x10-3 (Table 1). In previous studies, the mutation rate 
attributed to somatic hypermutation during antigen-specific responses has been calculated at1-
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4x10-3 per cell division [15-16]. Our results show that the B220+/IgM+/IgD+ B cells we have 
identified in non-lymphoid tissues had undergone substantially less mutations than B cells 
undergoing somatic hypermutation after a single division. This indicated that the 
B220+/IgM+/IgD+ B cells present in the non-lymphoid tissues were genuinely naive. Taken 
together, the results from the experiments described here suggest that naïve B cells are not only 
present in the non-lymphoid tissues, but that they also constitute the majority of B cells in the 
periphery. 
Naïve B cells migrate through peripheral tissues 
Having established that the majority of the total B cells in non-lymphoid tissues were naïve, we 
went on to examine whether they represented a resident population or whether passage through 
the non-lymphoid tissues was part of the naïve B cell migration pathway. The primary 
chemokine receptor involved in the entry and retention of lymphocytes in the lymph nodes is 
CCR7 with its ligands, CCL21 and CCL19 present on HEVs (CCL21) and stromal cells (CCL21 
and CCL19) within the T cell zones [20].  Exit from the lymph nodes is facilitated by the 
expression of sphingosine-1-phosphate receptor 1 (S1P1) which appears to mediate its effects by 
overriding CCR7 retention signals [21]. Since blocking of S1P1 with the immunosuppressant 
FTY720 prevents egress of lymphocytes from the lymph nodes, use of this molecule would 
allow us to establish whether peripheral tissue naïve B cells moved through the lymph nodes as 
part of their normal migration pathway. Therefore, mice were treated with FTY720 in their 
drinking water for three days before lymphocyte isolation from perfused organs and staining for 
CD19 or B220, IgM and IgD. As expected, total B cell numbers significantly increased in the 
MLN and PLN and significantly decreased in the peripheral tissues (Fig. 3A) after FTY720 
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treatment. When the naïve B cell population was examined alone, again as expected, the 
numbers significantly increased in the MLN and PLN (Fig. 3B). In all the peripheral tissues 
examined naïve B cell numbers significantly decreased, indicating that these cells were no longer 
able to follow their normal migration pathway from (presumably) the blood to the non-lymphoid 
tissues (Fig. 3B). 
Chemokine-mediated signalling is not required to enter the liver or lung parenchyma 
Chemokine signalling is critical for lymphocyte trafficking through tissues under both normal 
and inflamed conditions [22-23]. For example, studies have shown that the expression of the 
chemokine receptors CCR9 and CCR10 is necessary for lymphocyte homing to the intestine and 
skin, respectively [24] and, as discussed, signalling through CCR7 is necessary for lymphocyte 
entry into the lymph nodes. Given the findings of these studies, we wondered whether 
chemokine-mediated signalling might be required for lymphocyte entry into other peripheral 
sites such as the liver or lungs. To this end pertussis toxin (PTX) treated, CFSE-labelled B cells 
were transferred into recipient mice and after 2 days the mice were sacrificed and lymphocytes 
isolated from both lymphoid and non-lymphoid tissues. Numbers of CFSE-labeled cells were 
determined as a percentage of the total B cell population within each organ. As expected, in the 
lymph nodes, the percentage of CFSE-labeled B cells was significantly decreased in the PTX-
treated mice compared to the controls (Fig. 4A and B) indicating that chemokine-mediated 
signaling was required for B cells to enter these tissues. However, in the liver and lung, B cell 
numbers were significantly increased in the PTX-treated mice relative to the controls (Fig. 4B) 
suggesting that, in the absence of directed lymph node migration, there is no absolute 
requirement for chemokine mediated signaling for B cells to access the liver and lung. A similar 
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pattern could be seen when absolute numbers of CFSE+ cells were plotted (Fig. S8). No data was 
obtained for B cell migration to the LP since <5% of B220+ cells expressed CCR9. We would, 
therefore, expect few cells to migrate efficiently to the intestine, whether PTX treated or 
otherwise. 
Discussion 
The data presented here suggests that, when examined by phenotypic and sequence analysis, the 
majority of the B cells found in non-lymphoid tissues are similar to the naïve B cells in organised 
lymphoid tissue. There are two possible explanations for this: either the naïve B cell population 
in lymphoid tissue is not truly naive or naïve B cells constitute a large proportion of the B 
lymphocytes in peripheral tissue.  Given the numerous studies performed using naive B cells 
from lymphoid tissue, the former explanation seems unlikely. The other possibility, that the 
majority of B cells in the non-lymphoid tissues are in fact naïve, is in conflict with the 
established models of lymphocyte recirculation.  
The use of techniques for analysis of surface phenotype to identify populations of memory and 
naïve B cells is well established [18, 25] and we were unable to differentiate between naïve B 
cells from non-lymphoid and organised lymphoid tissue using this method. The exception to this 
was CD62L expression which decreased on naïve B cells in the SPL, LIV and LP. This is in 
contrast to what has been shown to occur on memory B cells, in that CD62L is present at higher 
levels.  Why naïve B cells express lower levels of CD62L in these tissues is unclear; CD62L is 
known to be shed upon engagement [26] and this molecule may be playing a role in either 
extravasation into the underlying tissue, or in the migration of B cells within the tissue. In the 
intestinal LP, the picture was a little less clear than in the lung and liver, since levels of 
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expression of both CD73 and CD86 were higher when compared to cells from lymphoid tissue.  
Other leukocytes from the intestine have an unusual phenotype and function [27-28], so it is 
possible that intestinal B cells may also be phenotypically different to naïve B cells from the 
systemic immune system.  For example, the expression of the ectoenzyme CD73 [29] by these 
cells may contribute to the regulated immune environment present in normal intestine.  
Although phenotypic analysis is a useful first step to screen for the presence of naïve 
lymphocytes in non-lymphoid tissue, the results obtained using this method are not conclusive. 
Therefore, we used somatic hypermutation as a more robust method of distinguishing between 
naïve and memory/effector B cells [19].  Our results show that the mutation frequency in the B 
cells from the non-lymphoid tissues is no different from that in the PLN. It is possible that the 
cells we have identified represent a subset of B cells that have encountered antigen in a T-cell 
independent manner without undergoing somatic hypermutation. For example, B1b cells have 
been shown to expand in a T-cell independent manner in response to microbial stimulation [30]. 
However, somatic hypermutation has been shown to occur in the absence of T cell help [31] and, 
specifically, somatic hypermutation has been demonstrated in B1b cells [32]. In addition, both 
B1a and B1b cells can be characterised by their low levels of expression of B220 and IgD [32].  
The B cells identified in our work have comparable levels of expression of these molecules with 
the naïve population present in organised lymphoid tissue. In addition, B220 and IgD are both 
progressively down regulated during plasma cell development so that mature plasma cells are 
negative for the surface expression of both molecules [33], although the possibility remains that 
some of the cells we observed were very immature plasma cells.  
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Having established that the IgM+/IgD+ B cells in the non-lymphoid tissues were most likely to 
constitute a population of naïve cells, we went on to examine how these lymphocytes might be 
getting in to the tissues. The observation that FTY720 treatment depleted these cells from the 
non-lymphoid organs indicates that they are also functionally naïve; it is well established that 
this treatment prevents the movement of naïve lymphocytes out of the lymph nodes [21]. We 
propose, therefore, that naive B cells re-circulate through the peripheral tissues as part of their 
normal migration pathway. Whilst it is possible that these cells undergo apoptotic events within 
peripheral tissues instead, this seems unlikely given that the PTX experiments indicate that under 
normal circumstances they would be trafficking through to the lymph nodes. However, we 
accept that the studies presented here do not definitively demonstrate re-circulation of these cells 
through the tissues.  
If, as we propose, naïve B cells do in fact re-circulate through the non-lymphoid tissues, it is 
important to consider how they gain access to these sites. Our preliminary experiments using 
PTX indicate that B cells do not use chemokine receptor-ligand interactions to achieve this. This 
is in concordance with previous studies suggesting that naïve T cells do not utilise these 
pathways [9]. It seems likely, therefore, that other, G- i-independent, signalling allows access 
into the peripheral tissues. For example, it is possible that expression of the lower affinity 
conformation of LFA-1 by naïve B cells would allow extravasation from the vasculature by a G-
i-independent, chemokine-independent mechanism.  
Having established that a large proportion of the total B cells in the peripheral tissues are naïve, a 
question not addressed in this study is why these cells would migrate through non-lymphoid 
tissues. One possibility is the regulation of autoreactive T cells directly in the local tissues [34].  
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In addition, naïve B cells produce IL-10 upon TLR [35], but not BCR, ligation [36]. Thus, there 
may be a role for naïve B cells in direct regulation of immune responses in the intestine. Other 
studies have shown resting splenic B cells to be capable of expanding the regulatory T cell 
population through production of TGF-β3. This ability is reduced upon activation [37]. Another 
possible role for naïve B cells in peripheral tissues, therefore, may be the maintenance of local 
tolerance by supporting the regulatory T cell population. In either case, the migration of naïve B 
cells through the peripheral tissues will ensure that they come into contact with foreign and 
tissue-specific autoantigens outside of the lymph nodes. Given the specialised 
microenvironments in organised lymphoid tissues, the outcome of antigen binding in the 
peripheral tissues via the BCR may be somewhat different to the outcome of activation in the 
lymph nodes. 
The evidence presented in this study suggests that naïve B cells migrate through non-lymphoid 
tissues and, in fact, make up the majority of the B cell population in these organs. These 
findings, combined with the results from previous studies that have indicated that naïve T 
lymphocytes may also access the peripheral tissues [8-11] suggest that the established paradigm 
of naïve and memory lymphocyte recirculation may need to be redefined. Clearly, further studies 
are required. Certainly, the finding that the majority of B lymphocytes in non-lymphoid tissues 
are naïve seems likely to be functionally significant and future studies based around this 
hypothesis may shed light on the role that the non-lymphoid tissues may play in modulation of 
immune responses. 
14 
 
Methods 
Mice 
Female C57BL/6 mice, aged 6-10 weeks were purchased from Harlan UK and kept on site under 
specific pathogen-free conditions. 
FTY720 
FTY720 (Cayman Europe) was dissolved in PBS and administered to mice in their drinking 
water daily at 2 µg/ml for three days prior to sacrifice.  Mice were also given an initial dose of 6 
µg FTY720 by gavage prior to placing them on the treated water. 
Pertussis toxin (PTX), CFSE and adoptive transfer 
For PTX treatment, splenocytes were resuspended in PBS at 10 x 106 cells/ml and incubated with 
(or without) 20 ng/ml PTX (Sigma) for 10 minutes at 37°C.  At the same time, the cells were 
labelled with 5 mM CFSE (Molecular Probes), washed once in RPMI containing 10% FBS 
(Invitrogen), and a further two times in PBS prior to injecting 15 x 106 cells IV into recipient 
mice. Two days later mice were sacrificed and cells isolated from various organs.  Transferred 
CFSE+ B cells were identified using CD19 and CFSE.  Total recovered CFSE+ CD19+ B cells 
were determined by multiplying the total cell count by the percentage of CFSE+ CD19+ cells 
obtained by flow cytometry. 
Lymphocyte isolation and flow cytometry 
Lymphocytes from the various tissues were isolated as previously described [9]. Briefly, single 
cell suspensions from PLN, MLN and Spleen were made by mashing the tissues between frosted 
glass slides. For liver and lung tissue, the organs were first cut into small pieces.  These organs 
(PLN, MLN, spleen, liver and lungs) were then incubated in HBSS containing 1.3mM EDTA for 
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20 minutes.  The tissues were then incubated in a collagenase solution (RPMI/5% FBS/1mM 
MgCL2/1mM CaCl2/150 U/ml collagenase) for 30 minutes.  After incubation, the tissues were 
then forced through a 40mm mesh.  PLN, MLN and spleen were then kept on ice until needed.  
Liver and lung suspensions were spun down, resuspended in 67% Percoll solution (23% RPMI 
and 67% Percol, v/v), underlayed beneath a 44% Percoll solution and spun at 2000 rpm for 20 
minutes.  Cells at the interface were taken, washed and kept on ice until needed.  For isolation of 
lamina propria cells, the small intestines of mice were first flushed through with HBSS before 
cutting the intestine into small pieces.  These pieces were then washed three times in CMF 
solution (1X HBSS/1X HEPES Bicarbonate/2% FBS) followed by incubation with DTE solution 
(CMF/10% FBS/154mg dithioerithritol (DTE) per ml) for 20 minutes.  This was performed three 
times, discarding the supernatant after each incubation.  Gut pieces were then treated as with the 
lung and liver tissues.  Following isolation, lymphocytes were stained with a cocktail of 
antibodies containing unlabelled anti-CD16/32 (2.4G2), anti-IgD-FITC (11-26c.2a), anti-B220-
PerCP/Cy5.5 (RA3-6B2) and one of the following: PE-labelled anti-CD11a (2D7), -CD40 
(3/23), -CD44 (IM7), -CD69 (H1.2F3), -CD62L (MEL-14), -CD73 (TY/23), -CD80 (16-10A1), -
CD86 (GL1), -CD95 (Jo2), -anti-MHC Class II (AF6-120.1), -anti-CCR9 (clone 242503, RnD 
Systems) or biotinylated anti-IgM (R6-60.2) followed by Streptavidin-PE (eBioscience).  Unless 
otherwise stated, all antibodies were purchased from BD Pharmingen.  For some experiments 
anti-CD19 (1D3) was used instead of anti-B220.  Cells were collected on an EPICS-MCL 
(Beckman Coulter) and analysed using FlowJo software (Treestar).  For cell sorting, 
lymphocytes were stained with unlabelled antiCD16/32, FITC-labelled anti-IgD, biotinylated 
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anti-IgM followed by PE-labelled Streptavidin and PerCP/Cy5.5-labelled anti-B220.  Cells were 
sorted on a FACS Vantage (Becton Dickinson) and were routinely ≥ 98% pure. 
Immunohistology and image analysis 
Whole organs from perfused mice were embedded in OCT (Tissue TEK, BDH) medium and 
snap frozen in isopentane pre-cooled to -70°C.  To ensure architectural integrity, the lungs and 
small intestine were inflated with 1 ml 30% OCT medium in PBS following perfusion, before 
snap freezing and sectioning. 10% rat serum in PBS was applied to each section for 1 hour at 
room temperature before staining. Tissues were stained with pre-titrated FITC-labelled anti-IgD 
and PE-labelled anti-B220 and, for some experiments, biotinylated anti-CD31 (clone MEC13.3) 
(all from BD Pharmingen). Biotinylated anti-CD31 was detected with Streptavidin-AMCA 
(Vector Laboratories) or Streptavidin-AlexaFluor 633 (Invitrogen). The slides were mounted 
using Vectashield (Vector Laboratories) with or without DAPI. Negative control slides were 
prepared in conjunction with each positively stained slide. Between 6 and 10 grey scale images 
per tissue of each stain from each mouse were captured using a Leica DMR-A fluorescence 
microscope (Leica) fitted with appropriate single-color filters and a Hamamatsu Orca-ER camera 
(Hamamatsu) and Q-fluoro software (Leica). Images were analysed as described previously 
using ImageJ [38]. Briefly, a region of interest (ROI) was identified for each image (e.g. ROIs in 
the intestine included the mucosa and excluded the epithelium and unstained area outside the 
tissue) and levels of background staining (threshold levels) in all colour channels were obtained 
from negative control slides. These were then applied to the positively stained images so that all 
pixels with intensity above threshold were counted as positive and all those below were counted 
as negative. The proportion of area of each single colour or combination of colours within the 
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image was calculated as described [38-39]. Preferential co-localization of fluorochromes was 
determined by comparisons of the observed proportional area of each colour combination with 
those predicted from a null hypothesis that each element of positive staining (e.g. B220+ and 
CD31+) was randomly and independently distributed (the “expected” area of staining [38]). In 
addition, manual cell counts of B220+IgD+ cells were carried out for each image. 
Sequencing 
Genomic DNA was extracted from 105 sorted cells as per manufacturers guidelines (Machery 
Nagel).  An initial PCR was performed to amplify an ~1.2 Kb fragment spanning the J-C intron 
of VHJ558 family members, using primers specific for VHJ558 (GGA ATT CGC CTG ACA 
TCT GAG GAC TCT GC) and a sequence located at the 3’ end of the IgH intronic enhancer 
(GAC TAG TCC TCT CCA GTT TCG GCT GAA TCC) [19].  PCR conditions consisted of one 
cycle at 95°C, 35 cycles of 95°C for 15 seconds, 59°C for 30 seconds and 72°C for two minutes, 
followed by a single cycle of 72°C for 10 minutes.  No product could be visualised after a first 
round cycle, so 1 µl of the first round PCR reaction was used as template in a second round PCR 
reaction, using an internal 5’ primer (JH4 - TAT GCT ATG GAC TAC TGG) and the above 
primer located at the 3’ end of the IgH intronic enhancer.  PCR products were then cloned into 
the pGEM-T vector (Invitrogen) and competent E.coli DH5α (Invitrogen) transformed.  Colonies 
containing the insert were grown overnight and plasmid mini-preps (Qiagen) obtained.  Plasmids 
were either sequenced directly, or subjected to a further round of PCR (25 cycles).  In this case, 
positive PCR products were cleaned up (Machery Nagel) and then sequenced.  Sequencing using 
the JH4 primer was performed by The Sequencing Service (University of Dundee, UK) using 
HotStarTaq DNA Polymerase (Qiagen). 
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Statistics 
All statistical tests were performed using SPSS. For the immunohistology results, the area of 
positive staining was calculated for each staining combination and the data were compared using 
a Wilcoxon signed ranks test. Observed areas of staining were compared to expected areas using 
a Wilcoxon signed ranks test.  Manual cell counts of B220+IgD+ cells in the tissue parenchyma 
and associated with blood vessels were also compared using a Wilcoxon signed ranks test. For 
all other results, data was tested for normal distribution using an F-test and was analysed for 
statistical significance using ANOVA.         
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Figure Legends 
Figure 1.  B cells in peripheral tissues have a naïve phenotype. 
Lymphocytes were isolated from the indicated organs of perfused, uninfected mice and stained 
with antibodies to CD19, IgM and IgD. (A) Representative plots are gated (CD19+) B cells.  
Numbers within each plot represent the percentage of gated B cells falling into each indicated 
quadrant.  (B) Collated data show the percent of B cells within the whole lymphocyte population 
(open bars) and the proportion of those B cells co-expressing IgM and IgD (closed bars).  n = 5-9 
different experiments, with 2-4 organs combined per experiment for lung, liver and LP.  Error 
bars represent the SD. 
Figure 2.  Naïve B cells present in non-lymphoid tissues are not associated with blood 
vessels. 
(A) B220+ IgD+ cells (indicated by arrows) within the parenchymal tissues of the indicated 
organs. B220 (red), IgD (green) and CD31 (blue). Scale bar in the top left hand corner represents 
10µm. (B) With the exception of the lung, there was significantly more B220+/IgD+/CD31- area 
than B220+/IgD+/CD31+ area in all tissues (B220+/IgD+/CD31- area, black diamonds; 
B220+/IgD+/CD31+ area, open triangles). Data were compared using a Wilcoxon Signed Ranks 
test. SPL * p=0.08 x10-6; LIV * p=0.02 x10-5; LP * p=0.01; LUNG  p=0.149. Each data point 
represents one image (40 images from LIV, 25 images from LUNG and 35 images from LP). 
LIV and LP taken from 4 mice, LUNG taken from 3 mice. Prior to thresholding, the analysis was 
carried out on unmanipulated images. 
Figure 3.  Naïve B cells migrate through peripheral tissues. 
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Mice were treated with FTY720 in their drinking water for three days after which lymphocytes 
were isolated from the perfused organs and stained for CD19 or B220, IgM and IgD.  Data 
represents the absolute number of B cells (A) or the absolute number of IgM+/IgD+ cells (B) in 
treated (open bars) or untreated (closed bars) controls.  n>8 mice for both treated and untreated 
groups.  Error bars represent SD. Data were tested for normal distribution using an F-test and 
then compared using ANOVA. *, p<0.05; **, p<0.005.  
Figure 4. Chemokine-mediated signalling by B cells is not required to enter the liver or 
lung parenchyma. 
MACS-enriched B cells were CFSE-labeled and incubated without or with PTX prior to 
injecting 15 x 106 cells into recipient mice.  Lymphocytes from perfused organs were isolated 
two days later. Very few transferred cells, treated or otherwise, could be isolated from LP. 
(A) Representative flow cytometry histograms showing CFSE labelled B cells in organised 
lymphoid tissues, liver and lung after adoptive cell transfer without (top row) and with (bottom 
row) PTX treatment. (B)  Transferred CFSE-labeled cells incubated without (closed bars) or with 
(open bars) PTX represented as a percentage of the total B cell population in the given organ. 
Error bars represent the SD. Data were tested for normal distribution using an F-test and then 
compared using ANOVA.  Asterisks represent significance compared to the untreated control (*, 
p<0.05; **, p=0.05); n=4 for treated and untreated groups.   
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Table legends. 
Table 1. Sequence analysis reveals no difference between tissue resident IgM+/IgD+ B cells 
and their naïve lymph node counterparts. 
Data show the number of sequences obtained for each tissue, the percent of sequences with less 
than three mutations across the 500 bp fragment, and the number of mutations per 100 bp +/- SD.  
Data were tested for normal distribution using an F-test and then compared using ANOVA. No 
significant difference was observed between sequences obtained from PLN versus any other 
tissue. 1-2 x 105 sorted cells were obtained from the combined tissues of two mice (for PLN, 
Liver and Lung) or eight mice (for LP). 
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Table 1. 
 PLN Lung Liver LP 
Number sequences 18 17 11 20 
% with < 3 mutations 89 94 82 90 
Mutations/100 bp 0.2 +/- 0.3 0.2 +/- .03 0.4 +/- 0.3 0.3 +/-0.2 
 
 
